Luis M. Allende

Luis M. Allende

Auto-generated profile, based on publicly available information

Luis M. Allende

Immunology Department University Hospital 12 de Octubre Madrid Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2001 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
AAAntonio Arnaiz-Villena
Antonio Arnaiz-Villena
JMJorge Martinez‐Laso
Jorge Martinez‐Laso
MCMaria Jose Castro
Maria Jose Castro
PMPablo Morales
Pablo Morales
JMJuan Moscoso
Juan Moscoso
LALuis M. Allende
Luis M. Allende

21 March 2024 in Immunology
Verified
Journal Article
Open access
ACAne Calvo‐Apalategi
Ane Calvo‐Apalategi
MNMarta López Nevado
Marta López Nevado
LBLuz Yadira Bravo‐Gallego
Luz Yadira Bravo‐Gallego
Luis Ignacio González-GranadoLuis Ignacio González-Granado
Luis Ignacio González-Granado
LALuis M. Allende
Luis M. Allende
Hugh Thomson ReyburnHugh Thomson Reyburn
Hugh Thomson Reyburn
Analysis of genetically defined immunodeficient patients allows study of the effect of the absence of specific proteins on human immune function in real‐world conditions. Here we have addressed the importance of type I interferon signalling for human NK cell development by studying the phenotype and function of circulating NK cells isolated from patients suffering primary immunodeficiency disease due to mutation of either the human interferon regulatory factor 9 (IRF9) or the signal transducer and activator of transcription 2 (STAT2) genes. IRF9, together with phosphorylated STAT1 and STAT2, form a heterotrimer called interferon stimulated gene factor 3 (ISGF3) which promotes the expression of hundreds of IFN‐stimulated genes that mediate antiviral function triggered by exposure to type I interferons. IRF9‐ and STAT2‐deficient patients are unable to respond efficiently to stimulation by type I interferons and so our experiments provide insights into the importance of type I interferon signalling and the consequences of its impairment on human NK cell biology. Surprisingly, the NK cells of these patients display essentially normal phenotype and function.